Tag: Vaccines
Immune Responses to Ebola Vaccines Persist at One Year
All active vaccine recipients maintained Ebola virus-specific immunoglobulin responses at day 360
Post-PCV13 Drop in Streptococcus pneumoniae Bacteremia
As pneumococcal rates dropped, rates of E. coli, Salmonella spp, Staphylococcus aureus increased
CDC: Influenza Vaccine 48 Percent Effective Overall
More severe H3N2 strain a factor in reduced coverage
Reduced Immune Response After Intradermal Flu Shot in Eczema
Reduced immune response after intradermal vaccination among patients colonized with S. aureus
AAP: Improvement Needed in Adolescent Vaccination Rates
HPV, influenza immunization rates remain well below goals, says American Academy of Pediatrics
CDC Issues Updated Immunization Schedule
CDC panel revises immunization advisory for vaccines in adults
Early Study Results Promising for Genital Herpes Vaccine
Two-pronged approach tested on lab monkeys, guinea pigs
Effectiveness of One-Dose MenACWY-D Drops Over Time
Effectiveness 79 percent at less than one year, drops to 61 percent at three to less than eight years
Bell’s Palsy Tied to Quadrivalent Meningococcal Vaccine
Increased risk for Bell's palsy in those with concomitant administration of other vaccines
Optimal Timing ID’d for Flu Shot During Three-Week Chemo Cycle
Comparable antibody responses for influenza vaccination on day one or 11 of chemo cycle
